RT Journal Article
SR Electronic
T1 First peak of COVID-19 outbreak in Japan might pass as of April 26, 2020
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.26.20081315
DO 10.1101/2020.04.26.20081315
A1 Junko Kurita
A1 Tamie Sugawara
A1 Yasushi Ohkusa
YR 2020
UL http://medrxiv.org/content/early/2020/05/01/2020.04.26.20081315.abstract
AB Background The COVID-19 outbreak has two inconsistent phenomena: its reproduction number is almost two; and it shows earlier and lower peaks for new cases and the total number of patients.Object To resolve this difficulty, we constructed a mathematical model that can explain these phenomena.Method We applied a susceptible–infected–recovery model with the proportion of asymptomatic patients among the infected (q) as a key parameter for estimation as well as the basic reproduction number (R0).Results We observed the first outbreak peak in Japan on April 3 for those infected on March 29. Their R0 and q were estimated respectively as 2.048 and 99.987%. Discussion and Conclusion: By introducing a very high proportion of asymptomatic cases, two inconsistent phenomena might be resolved. This hypothesis should be verified through additional study.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe author(s) received no specific funding for this work.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesJapan Ministry of Health, Labour and Welfare. Press Releases. https://www.mhlw.go.jp/stf/newpage_10723.html